...
首页> 外文期刊>Cerebrovascular diseases >Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: Systematic review and meta-analysis
【24h】

Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: Systematic review and meta-analysis

机译:腔隙性卒中与非腔隙性卒中和非卒中的凝血,纤维蛋白溶解,内皮功能障碍和炎症的血液标志物:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例

摘要

Background: The cause of cerebral small vessel disease is not fully understood, yet it is important, accounting for about 25% of all strokes. It also increases the risk of having another stroke and contributes to about 40% of dementias. Various processes have been implicated, including microatheroma, endothelial dysfunction and inflammation. A previous review investigated endothelial dysfunction in lacunar stroke versus mostly non-stroke controls while another looked at markers of inflammation and endothelial damage in ischaemic stroke in general. We have focused on blood markers between clinically evident lacunar stroke and other subtypes of ischaemic stroke, thereby controlling for stroke in general. Summary: We systematically assessed the literature for studies comparing blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-stroke controls or other ischaemic stroke subtypes. We assessed the quality of included papers and meta-analysed results. We split the analysis on time of blood draw in relation to the stroke. We identified 1,468 full papers of which 42 were eligible for inclusion, including 4,816 ischaemic strokes, of which 2,196 were lacunar and 2,500 non-stroke controls. Most studies subtyped stroke using TOAST. The definition of lacunar stroke varied between studies. Markers of coagulation/fibrinolysis (tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI), fibrinogen, D-dimer) were higher in lacunar stroke versus non-stroke although fibrinogen was no different to non-stroke in the acute phase. tPA and PAI were no different between lacunar and non-lacunar stroke. Fibrinogen and D-dimer were significantly lower in lacunar stroke compared to other ischaemic strokes, both acutely and chronically. Markers of endothelial dysfunction (homocysteine, von Willebrand Factor (vWF), E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM), vascular cellular adhesion molecule-1 (VCAM)) were higher or had insufficient or conflicting data (P-selectin, VCAM) in lacunar stroke versus non-stroke. Compared to other ischaemic stroke subtypes, homocysteine did not differ in lacunar stroke while vWF was significantly lower in lacunar stroke acutely [atherothrombotic standardized mean difference, SMD, -0.34 (-0.61, -0.08); cardioembolic SMD -0.38 (-0.62, -0.14)], with insufficient data chronically. Markers of inflammation (C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6)) were higher in lacunar stroke versus non-stroke, although there were no studies measuring TNF-α chronically and the sole study measuring IL-6 chronically showed no difference between lacunar stroke and non-stroke. Compared to other ischaemic stroke subtypes, there was no difference (CRP) or insufficient or conflicting data (TNF-α) to lacunar stroke. IL-6 was significantly lower [atherothrombotic SMD -0.37 (-0.63, -0.10); cardioembolic SMD -0.52 (-0.82, -0.22)] in lacunar stroke acutely, with insufficient data chronically. Key Messages: Lacunar stroke is an important stroke subtype. More studies comparing lacunar stroke to non-lacunar stroke specifically, rather than to non-stroke controls, are needed. Prospective studies with measurements taken well after the acute event are more likely to be helpful in determining pathogenesis. The available data in this review were limited and do not exclude the possibility that peripheral inflammatory processes including endothelial dysfunction are associated with lacunar stroke and cerebral small vessel disease.
机译:背景:脑小血管疾病的病因尚不完全清楚,但很重要,约占所有中风的25%。它还增加了再次中风的风险,并导致约40%的痴呆症。已经牵涉到各种过程,包括微动脉粥样硬化,内皮功能障碍和炎症。先前的一篇综述调查了腔隙性卒中与大多数非卒中性对照的内皮功能障碍,而另一篇则着眼于缺血性卒中的炎症和内皮损伤的标志物。我们将重点放在临床上明显的腔隙性卒中与缺血性卒中其他亚型之间的血液标志物上,从而总体上控制了卒中。摘要:我们系统地评估了文献,以比较腔隙性卒中与非卒中对照或其他缺血性卒中亚型的凝血,纤维蛋白溶解,内皮功能障碍和炎症的血液标志物进行比较。我们评估了纳入论文的质量和荟萃分析的结果。我们将抽血时间与中风的相关分析分开。我们确定了1,468篇全文,其中42篇符合纳入标准,包括4,816例缺血性中风,其中2,196例腔隙性卒中和2,500例非中风对照。大多数研究使用TOAST将中风分为亚型。腔隙性中风的定义因研究而异。腔隙性卒中的凝结/纤维蛋白溶解指标(组织纤溶酶原激活物(tPA),纤溶酶原激活物抑制剂(PAI),纤维蛋白原,D-二聚体)高于非卒中,尽管在急性期纤维蛋白原与非卒中无差异。腔隙性和非腔隙性卒中的tPA和PAI无差异。与其他局部缺血性卒中相比,腔隙性卒中的纤维蛋白原和D-二聚体在急性和慢性方面均显着降低。内皮功能障碍的标记(同型半胱氨酸,von Willebrand因子(vWF),E-选择素,P-选择素,细胞间黏附分子1(ICAM),血管细胞黏附分子1(VCAM))较高或数据不足或冲突(腔隙性卒中与非卒中的P-选择素(VCAM)。与其他缺血性卒中亚型相比,腔隙性脑卒中的同型半胱氨酸水平没有差异,而腔隙性脑卒中的vWF明显降低[动脉粥样硬化血栓形成标准平均差异,SMD,-0.34(-0.61,-0.08);心脏栓塞SMD -0.38(-0.62,-0.14)],长期数据不足。尽管没有测量TNF-α的研究,腔隙性脑卒中的炎症标志物(C反应蛋白(CRP),肿瘤坏死因子-α(TNF-α),白介素-6(IL-6))较高。长期进行α值研究和长期测量IL-6的唯一研究表明,腔隙性卒中和非卒中之间无差异。与其他缺血性中风亚型相比,腔隙性中风没有差异(CRP)或数据不足或冲突(TNF-α)。 IL-6明显较低[动脉粥样硬化血栓形成SMD -0.37(-0.63,-0.10);腔隙性卒中急性心源性SMD -0.52(-0.82,-0.22)],长期数据不足。重要信息:腔隙性中风是重要的中风亚型。需要更多的研究来比较腔隙性卒中与非腔隙性卒中,而不是非腔隙性对照。急性事件后进行良好测量的前瞻性研究更有可能有助于确定发病机理。该评价中的可用数据有限,并不排除包括内皮功能障碍在内的周围炎症过程与腔隙性中风和脑小血管疾病有关的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号